Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0002044770-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 29, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
6,254
Total Value
$0.00
P&L
+inf% (+$383,120.04)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (right to buy) | Derivative | Jun 25, 2026 | Grant/Award | 3,837 | $0.00 | $0.00 | 3,837 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Jun 25, 2026 | Grant/Award | 2,417 | $0.00 | $0.00 | 2,417 | Direct | โ | View Details |